Anderson Hoagland & Co’s AbbVie ABBV Stock Holding History

Anderson Hoagland & Co’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.08M	Sell	8,267 -1,018	-11%	-$219K	0.16%	93
2026 Q1	$2.02M	Sell	9,285 -1,060	-10%	-$235K	0.17%	98
2025 Q4	$2.36M	Hold	10,345	–	–	0.2%	94
2025 Q3	$2.4M	Buy	10,345 +7,851	+315%	+$1.6M	0.21%	92
2025 Q2	$463K	Buy	2,494 +60	+2%	+$11.2K	0.04%	128
2025 Q1	$428K	Hold	2,434	–	–	0.05%	121
2024 Q4	$418K	Hold	2,434	–	–	0.04%	124
2024 Q3	$473K	Sell	2,434 -217	-8%	-$40.5K	0.05%	118
2024 Q2	$446K	Hold	2,651	–	–	0.05%	119
2024 Q1	$448K	Buy	2,651 +217	+9%	+$37.4K	0.05%	115
2023 Q4	$393K	Hold	2,434	–	–	0.05%	108
2023 Q3	$363K	Buy	+2,434	New	+$357K	0.05%	112
2018 Q3	–	Sell	-11,875	Closed	-$1.1M	–	91
2018 Q2	$1.1M	Hold	11,875	–	–	0.61%	56
2018 Q1	$1.12M	Buy	11,875 +4,770	+67%	+$524K	0.65%	51
2017 Q4	$687K	Buy	+7,105	New	+$670K	0.4%	75

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Anderson Hoagland & Co's ABBV Position: Q2 2026 in Review

Anderson Hoagland & Co reduced its AbbVie (ABBV) stake by 11% in Q2 2026, selling an estimated $219K and leaving 8,267 shares worth $2.08M. The position accounts for 0.16% of the portfolio, ranked #93.

Anderson Hoagland & Co first reported a position in ABBV in Q4 2017 and has held it in 15 quarters since. The position peaked at $2.4M in Q3 2025. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Anderson Hoagland & Co held 8,267 shares of AbbVie worth $2.08M as of Q2 2026.
Anderson Hoagland & Co sold 1,018 AbbVie shares in Q2 2026, an estimated $219K.
AbbVie made up 0.16% of Anderson Hoagland & Co's portfolio in Q2 2026, its #93 holding.
Anderson Hoagland & Co first reported a position in AbbVie in Q4 2017 and has held it in 15 quarters since.
Anderson Hoagland & Co's AbbVie position peaked at $2.4M in Q3 2025.
1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Anderson Hoagland & Co's 13F filing for Q2 2026, filed 6 Jul 2026.